Ahsanuddin, A.N., Brynes, R.K., Li, S., Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: report of 3 cases and review of the literature (2011) Int. J. Clin. Exp. Pathol., 4, pp. 416-420
Alcamo, E., Hacohen, N., Schulte, L.C., Rennert, P.D., Hynes, R.O., Baltimore, D., Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs (2002) J. Exp. Med., 195, pp. 233-244
Algul, H., Treiber, M., Lesina, M., Nakhai, H., Saur, D., Geisler, F., Pfeifer, A., Schmid, R.M., Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis (2007) J. Clin. Invest., 117, pp. 1490-1501
Bachmann, I.M., Halvorsen, O.J., Collett, K., Stefansson, I.M., Straume, O., Haukaas, S.A., Salvesen, H.B., Akslen, L.A., EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast (2006) J. Clin. Oncol., 24, pp. 268-273
Balmer, M.L., Ma, E.H., Bantug, G.R., Grahlert, J., Pfister, S., Glatter, T., Jauch, A., Dehio, P., Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function (2016) Immunity, 44, pp. 1312-1324
Bhat, P., Leggatt, G., Waterhouse, N., Frazer, I.H., Interferon-gamma derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity (2017) Cell Death Dis., 8, p. e2836
Burstein, E., Duckett, C.S., Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery (2003) Curr. Opin. Cell Biol., 15, pp. 732-737
Chaffin, K.E., Beals, C.R., Wilkie, T.M., Forbush, K.A., Simon, M.I., Perlmutter, R.M., Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase (1990) EMBO J., 9, pp. 3821-3829
Chang, C.H., Curtis, J.D., Maggi, L.B., Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., Qiu, J., Posttranscriptional control of T cell effector function by aerobic glycolysis (2013) Cell, 153, pp. 1239-1251
Chen, Z., Yang, P., Li, W., He, F., Wei, J., Zhang, T., Zhong, J., Cao, J., Expression of EZH2 is associated with poor outcome in colorectal cancer (2018) Oncol. Lett., 15, pp. 2953-2961
Chiche, J., Pommier, S., Beneteau, M., Mondragon, L., Meynet, O., Zunino, B., Mouchotte, A., Pages, G., GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-kappaB-dependent induction of HIF-1alpha (2015) Leukemia, 29, pp. 1163-1176
Cildir, G., Low, K.C., Tergaonkar, V., Noncanonical NF-kappaB signaling in health and disease (2016) Trends Mol. Med., 22, pp. 414-429
Colell, A., Green, D.R., Ricci, J.E., Novel roles for GAPDH in cell death and carcinogenesis (2009) Cell Death Differ., 16, pp. 1573-1581
Colell, A., Ricci, J.E., Tait, S., Milasta, S., Maurer, U., Bouchier-Hayes, L., Fitzgerald, P., Li, C.W., GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation (2007) Cell, 129, pp. 983-997
Cortes, J.R., Ambesi-Impiombato, A., Couronne, L., Quinn, S.A., Kim, C.S., da Silva Almeida, A.C., West, Z., Scourzic, L., RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis (2018) Cancer Cell, 33, pp. 259-273.e7
Crotty, S., T follicular helper cell differentiation, function, and roles in disease (2014) Immunity, 41, pp. 529-542
De Donatis, G.M., Le Pape, E., Pierron, A., Cheli, Y., Hofman, V., Hofman, P., Allegra, M., Rocchi, S., NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 (2016) Oncogene, 35, pp. 2735-2745
de Leval, L., Gisselbrecht, C., Gaulard, P., Advances in the understanding and management of angioimmunoblastic T-cell lymphoma (2010) Br. J. Haematol., 148, pp. 673-689
de Leval, L., Rickman, D.S., Thielen, C., Reynies, A., Huang, Y.L., Delsol, G., Lamant, L., Molina, T., The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells (2007) Blood, 109, pp. 4952-4963
DePristo, M.A., Banks, E., Poplin, R., Garimella, K.V., Maguire, J.R., Hartl, C., Philippakis, A.A., Hanna, M., A framework for variation discovery and genotyping using next-generation DNA sequencing data (2011) Nat. Genet., 43, pp. 491-498
Dimeloe, S., Mehling, M., Frick, C., Loeliger, J., Bantug, G.R., Sauder, U., Fischer, M., Tay, S., The immune-metabolic basis of effector memory CD4+ T cell function under hypoxic conditions (2016) J. Immunol., 196, pp. 106-114
Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.C., Gaulard, P., Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells (2006) Am. J. Surg. Pathol., 30, pp. 490-494
Federico, M., Rudiger, T., Bellei, M., Nathwani, B.N., Luminari, S., Coiffier, B., Harris, N.L., Savage, K.J., Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project (2013) J. Clin. Oncol., 31, pp. 240-246
Fradet, V., Lessard, L., Begin, L.R., Karakiewicz, P., Masson, A.M., Saad, F., Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer (2004) Clin. Cancer Res., 10, pp. 8460-8464
Fu, J., Malm, I.J., Kadayakkara, D.K., Levitsky, H., Pardoll, D., Kim, Y.J., Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors (2014) Cancer Res., 74, pp. 4042-4052
Fujioka, S., Son, K., Onda, S., Schmidt, C., Scrabas, G.M., Okamoto, T., Fujita, T., Yanaga, K., Desensitization of NFkappaB for overcoming chemoresistance of pancreatic cancer cells to TNF-alpha or paclitaxel (2012) Anticancer Res., 32, pp. 4813-4821
Galluzzi, L., Kepp, O., Vander Heiden, M.G., Kroemer, G., Metabolic targets for cancer therapy (2013) Nat. Rev. Drug Discov., 12, pp. 829-846
Gao, X., Wang, X., Pham, T.H., Feuerbacher, L.A., Lubos, M.L., Huang, M., Olsen, R., Hardwidge, P.R., NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation (2013) Cell Host Microbe, 13, pp. 87-99
Gardam, S., Sierro, F., Basten, A., Mackay, F., Brink, R., TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor (2008) Immunity, 28, pp. 391-401
Gaulard, P., de Leval, L., The microenvironment in T-cell lymphomas: emerging themes (2014) Semin. Cancer Biol., 24, pp. 49-60
Gerondakis, S., Fulford, T.S., Messina, N.L., Grumont, R.J., NF-kappaB control of T cell development (2014) Nat. Immunol., 15, pp. 15-25
Grinberg-Bleyer, Y., Oh, H., Desrichard, A., Bhatt, D.M., Caron, R., Chan, T.A., Schmid, R.M., Ghosh, S., NF-kappaB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer (2017) Cell, 170, pp. 1096-1108.e13
Grogg, K.L., Attygalle, A.D., Macon, W.R., Remstein, E.D., Kurtin, P.J., Dogan, A., Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified (2006) Mod. Pathol., 19, pp. 1101-1107
Guo, Z., Wang, H., Meng, F., Li, J., Zhang, S., Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer (2015) J. Transl. Med., 13, p. 247
Heissmeyer, V., Vogel, K.U., Molecular control of Tfh-cell differentiation by Roquin family proteins (2013) Immunol. Rev., 253, pp. 273-289
Hoesel, B., Schmid, J.A., The complexity of NF-kappaB signaling in inflammation and cancer (2013) Mol. Cancer, 12, p. 86
Hu, H., Wu, X., Jin, W., Chang, M., Cheng, X., Sun, S.C., Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development (2011) Proc. Natl. Acad. Sci. U S A, 108, pp. 12827-12832
Iqbal, J., Wright, G., Wang, C., Rosenwald, A., Gascoyne, R.D., Weisenburger, D.D., Greiner, T.C., Wilcox, R.A., Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma (2014) Blood, 123, pp. 2915-2923
Jacquin, M.A., Chiche, J., Zunino, B., Beneteau, M., Meynet, O., Pradelli, L.A., Marchetti, S., Ricci, J.E., GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death (2013) Cell Death Differ., 20, pp. 1043-1054
Jain, S., Chen, J., Nicolae, A., Wang, H., Shin, D.M., Adkins, E.B., Sproule, T.J., Kovalchuk, A.L., IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma (2015) Am. J. Pathol., 185, pp. 3102-3114
Jimi, E., Strickland, I., Voll, R.E., Long, M., Ghosh, S., Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes (2008) Immunity, 29, pp. 523-537
Johnston, R.J., Poholek, A.C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., Dent, A.L., Crotty, S., Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation (2009) Science, 325, pp. 1006-1010
Kakiuchi, M., Nishizawa, T., Ueda, H., Gotoh, K., Tanaka, A., Hayashi, A., Yamamoto, S., Watanabe, Y., Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma (2014) Nat. Genet., 46, pp. 583-587
Karakashev, S., Zhu, H., Wu, S., Yokoyama, Y., Bitler, B.G., Park, P.H., Lee, J.H., Yan, H., CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity (2018) Nat. Commun., 9, p. 631
Karin, M., Cao, Y., Greten, F.R., Li, Z.W., NF-kappaB in cancer: from innocent bystander to major culprit (2002) Nat. Rev. Cancer, 2, pp. 301-310
Kroemer, G., Pouyssegur, J., Tumor cell metabolism: cancer's Achilles' heel (2008) Cancer Cell, 13, pp. 472-482
Lavallard, V.J., Pradelli, L.A., Paul, A., Beneteau, M., Jacquel, A., Auberger, P., Ricci, J.E., Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells (2009) Cancer Res., 69, pp. 3013-3020
Li, B., Dewey, C.N., RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome (2011) BMC Bioinformatics, 12, p. 323
Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760
Liberti, M.V., Dai, Z., Wardell, S.E., Baccile, J.A., Liu, X., Gao, X., Baldi, R., Madhukar, N.S., A predictive model for selective targeting of the Warburg effect through GAPDH inhibition with a natural product (2017) Cell Metab., 26, pp. 648-659.e8
Lo, J.C., Basak, S., James, E.S., Quiambo, R.S., Kinsella, M.C., Alegre, M.L., Weih, F., Fu, Y.X., Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues (2006) Blood, 107, pp. 1048-1055
Long, M., Park, S.G., Strickland, I., Hayden, M.S., Ghosh, S., Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor (2009) Immunity, 31, pp. 921-931
Lund, K., Adams, P.D., Copland, M., EZH2 in normal and malignant hematopoiesis (2014) Leukemia, 28, pp. 44-49
Madonna, G., Ullman, C.D., Gentilcore, G., Palmieri, G., Ascierto, P.A., NF-kappaB as potential target in the treatment of melanoma (2012) J. Transl. Med., 10, p. 53
Morin, R.D., Johnson, N.A., Severson, T.M., Mungall, A.J., An, J., Goya, R., Paul, J.E., Kuchenbauer, F., Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin (2010) Nat. Genet., 42, pp. 181-185
Mourad, N., Mounier, N., Briere, J., Raffoux, E., Delmer, A., Feller, A., Meijer, C.J., Bosly, A., Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials (2008) Blood, 111, pp. 4463-4470
Muto, H., Sakata-Yanagimoto, M., Nagae, G., Shiozawa, Y., Miyake, Y., Yoshida, K., Enami, T., Uchida, K., Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice (2014) Blood Cancer J., 4, p. e264
Nagata, Y., Kontani, K., Enami, T., Kataoka, K., Ishii, R., Totoki, Y., Kataoka, T.R., Nakano, K., Variegated RHOA mutations in adult T-cell leukemia/lymphoma (2016) Blood, 127, pp. 596-604
Nagoshi, H., Kuroda, J., Kobayashi, T., Maegawa, S., Chinen, Y., Kiyota, M., Nakayama, R., Yamamoto-Sugitani, M., Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis (2013) Int. J. Hematol., 98, pp. 366-374
Ng, S.Y., Brown, L., Stevenson, K., deSouza, T., Aster, J.C., Louissaint, A., Jr., Weinstock, D.M., RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice (2018) Blood, 132, pp. 935-947
Palomero, T., Couronne, L., Khiabanian, H., Kim, M.Y., Ambesi-Impiombato, A., Perez-Garcia, A., Carpenter, Z., Haydu, J.E., Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas (2014) Nat. Genet., 46, pp. 166-170
Patnaik, M.M., Vallapureddy, R., Lasho, T.L., Hoversten, K.P., Finke, C.M., Ketterling, R., Hanson, C., Tefferi, A., EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental (2018) Blood Cancer J., 8, p. 12
Pearce, E.J., Pearce, E.L., Immunometabolism in 2017: driving immunity: all roads lead to metabolism (2018) Nat. Rev. Immunol., 18, pp. 81-82
Postow, M.A., Callahan, M.K., Wolchok, J.D., Immune checkpoint blockade in cancer therapy (2015) J. Clin. Oncol., 33, pp. 1974-1982
Raaphorst, F.M., van Kemenade, F.J., Blokzijl, T., Fieret, E., Hamer, K.M., Satijn, D.P., Otte, A.P., Meijer, C.J., Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease (2000) Am. J. Pathol., 157, pp. 709-715
Recaldin, T., Fear, D.J., Transcription factors regulating B cell fate in the germinal centre (2016) Clin. Exp. Immunol., 183, pp. 65-75
Ren, X.D., Schwartz, M.A., Determination of GTP loading on Rho (2000) Methods Enzymol., 325, pp. 264-272
Revillion, F., Pawlowski, V., Hornez, L., Peyrat, J.P., Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer (2000) Eur. J. Cancer, 36, pp. 1038-1042
Rohde, M., Richter, J., Schlesner, M., Betts, M.J., Claviez, A., Bonn, B.R., Zimmermann, M., Borkhardt, A., Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols (2014) Genes Chromosomes Cancer, 53, pp. 911-916
Roth, R.B., Hevezi, P., Lee, J., Willhite, D., Lechner, S.M., Foster, A.C., Zlotnik, A., Gene expression analyses reveal molecular relationships among 20 regions of the human CNS (2006) Neurogenetics, 7, pp. 67-80
Rupec, R.A., Jundt, F., Rebholz, B., Eckelt, B., Weindl, G., Herzinger, T., Flaig, M.J., Dorken, B., Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha (2005) Immunity, 22, pp. 479-491
Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Okuno, Y., Somatic RHOA mutation in angioimmunoblastic T cell lymphoma (2014) Nat. Genet., 46, pp. 171-175
Sasaki, D., Imaizumi, Y., Hasegawa, H., Osaka, A., Tsukasaki, K., Choi, Y.L., Mano, H., Yanagihara, K., Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy (2011) Haematologica, 96, pp. 712-719
Shen, H.M., Tergaonkar, V., NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy (2009) Apoptosis, 14, pp. 348-363
Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., Sirotkin, K., dbSNP: the NCBI database of genetic variation (2001) Nucleic Acids Res., 29, pp. 308-311
Shih, V.F., Tsui, R., Caldwell, A., Hoffmann, A., A single NFkappaB system for both canonical and non-canonical signaling (2011) Cell Res., 21, pp. 86-102
Sneeringer, C.J., Scott, M.P., Kuntz, K.W., Knutson, S.K., Pollock, R.M., Richon, V.M., Copeland, R.A., Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas (2010) Proc. Natl. Acad. Sci. U S A, 107, pp. 20980-20985
Stone, E.L., Pepper, M., Katayama, C.D., Kerdiles, Y.M., Lai, C.Y., Emslie, E., Lin, Y.C., Li, M.O., ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation (2015) Immunity, 42, pp. 239-251
Sudo, T., Utsunomiya, T., Mimori, K., Nagahara, H., Ogawa, K., Inoue, H., Wakiyama, S., Mori, M., Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma (2005) Br. J. Cancer, 92, pp. 1754-1758
Sun, S.C., The non-canonical NF-kappaB pathway in immunity and inflammation (2017) Nat. Rev. Immunol., 17, pp. 545-558
Topalian, S.L., Drake, C.G., Pardoll, D.M., Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity (2012) Curr. Opin. Immunol., 24, pp. 207-212
Topalian, S.L., Taube, J.M., Anders, R.A., Pardoll, D.M., Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy (2016) Nat. Rev. Cancer, 16, pp. 275-287
Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.C., Lanzavecchia, A., Manz, M.G., Development of a human adaptive immune system in cord blood cell-transplanted mice (2004) Science, 304, pp. 104-107
Vallois, D., Dobay, M.P., Morin, R.D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Roberti, A., Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas (2016) Blood, 128, pp. 1490-1502
Vasanthakumar, A., Liao, Y., Teh, P., Pascutti, M.F., Oja, A.E., Garnham, A.L., Gloury, R., Cuadrado, E., The TNF receptor superfamily-NF-kappaB axis is critical to maintain effector regulatory T cells in lymphoid and non-lymphoid tissues (2017) Cell Rep., 20, pp. 2906-2920
Visser, H.P., Gunster, M.J., Kluin-Nelemans, H.C., Manders, E.M., Raaphorst, F.M., Meijer, C.J., Willemze, R., Otte, A.P., The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma (2001) Br. J. Haematol., 112, pp. 950-958
Wang, K., Li, M., Hakonarson, H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data (2010) Nucleic Acids Res., 38, p. e164
Weber, B.S., Ly, P.M., Irwin, J.N., Pukatzki, S., Feldman, M.F., A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii (2015) Proc. Natl. Acad. Sci. U S A, 112, pp. 9442-9447
Weber, J.S., D'Angelo, S.P., Minor, D., Hodi, F.S., Gutzmer, R., Neyns, B., Hoeller, C., Lao, C.D., Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial (2015) Lancet Oncol., 16, pp. 375-384
Wee, Z.N., Li, Z., Lee, P.L., Lee, S.T., Lim, Y.P., Yu, Q., EZH2-mediated inactivation of IFN-gamma-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer (2014) Cell Rep., 8, pp. 204-216
Xiao, G., Harhaj, E.W., Sun, S.C., NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100 (2001) Mol. Cell, 7, pp. 401-409
Xie, P., Stunz, L.L., Larison, K.D., Yang, B., Bishop, G.A., Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs (2007) Immunity, 27, pp. 253-267
Xing, Y., Wang, X., Jameson, S.C., Hogquist, K.A., Late stages of T cell maturation in the thymus involve NF-kappaB and tonic type I interferon signaling (2016) Nat. Immunol., 17, pp. 565-573
Xu, H., Wang, X., Lackner, A.A., Veazey, R.S., PD-1(HIGH) follicular CD4 T helper cell subsets residing in lymph node germinal centers correlate with B cell maturation and IgG production in Rhesus macaques (2014) Front. Immunol., 5, p. 85
Xu, Y., Chaudhury, A., Zhang, M., Savoldo, B., Metelitsa, L.S., Rodgers, J., Yustein, J.T., Dotti, G., Glycolysis determines dichotomous regulation of T cell subsets in hypoxia (2016) J. Clin. Invest., 126, pp. 2678-2688
Yoo, H.Y., Sung, M.K., Lee, S.H., Kim, S., Lee, H., Park, S., Kim, S.C., Lee, J.E., A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma (2014) Nat. Genet., 46, pp. 371-375
Zehir, A., Benayed, R., Shah, R.H., Syed, A., Middha, S., Kim, H.R., Srinivasan, P., Devlin, S.M., Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients (2017) Nat. Med., 23, pp. 703-713
